Efficacy And Safety Of A Water-Free Cyclosporine 0.1% Formulation For The Treatment Of Dry Eye Disease: Results From Two Randomized Controlled Studies Essence-1 And Essence-2

Published 2023 - 41st Congress of the ESCRS

Reference: FP26.05 | Type: Free paper | DOI: 10.82333/dg7x-8q66